Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Therapeutic effect of suprachoroidal viscoelastic injection combined with 532 laser photocoagulation in treating rhegmatogenous retinal detachment.

Created on 31 May 2025

Authors

Weiguo Ma, Zengxi Wang, Zhen Li, Weining Rong, Qianwei Cui, Xuejun Hu

Published in

BMC ophthalmology. Volume 25. Issue 1. Pages 322. May 30, 2025. Epub May 30, 2025.

Abstract

To assess the therapeutic effect of suprachoroidal viscoelastic injection combined with 532 laser photocoagulation for the closure of retinal tears in the treatment of rhegmatogenous retinal detachment (RRD).
We retrospectively analyzed the clinical data of eight patients with RRD (eight eyes) who underwent suprachoroidal viscoelastic injection combined with 532-nm laser photocoagulation for the closure of tears at our hospital. The outcomes investigated were postoperative visual acuity and retinal reattachment.
The intraocular pressure (IOP) was significantly higher after surgery than before surgery (11.93 mmHg vs. 19.50 mmHg), and the best corrected visual acuity (BCVA) changed from 0.41 to 0.49, suggesting a significant improvement within 3 days post-surgery. In 7/8 eyes, the retina was well reattached postoperatively and follow-ups indicated stable condition. One patient experienced failed retinal reattachment and subsequently underwent vitrectomy combined with silicone oil tamponade. Three months after surgery, the silicone oil was removed, revealing successful reattachment of the retina.
In patients with RRD characterized by smaller retinal tears, more localized retinal detachment, and a proliferative vitreoretinopathy grade of ≤ C1, treatment incorporating suprachoroidal viscoelastic injection and 532-nm laser photocoagulation to seal the tears resulted in good postoperative recovery, with all patients achieving favorable visual acuity. However, due to the retrospective, non-comparative design without a control group, it is difficult to fully evaluate the relative efficacy of this treatment compared to other methods.
Not applicable.

PMID:
40448059
Bibliographic data and abstract were imported from PubMed on 31 May 2025.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 26
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement